Michael Gordon Selected Research

Michael Gordon Research Topics

Disease

27	Neoplasms (Cancer) 01/2023 - 03/2004
8	Colorectal Neoplasms (Colorectal Cancer) 10/2008 - 05/2005
7	Opioid-Related Disorders (Opiate Addiction) 01/2018 - 03/2015
5	Renal Cell Carcinoma (Grawitz Tumor) 12/2020 - 11/2007
5	Fatigue 12/2020 - 12/2017
4	Disease Progression 01/2021 - 04/2008
4	Carcinoma (Carcinomatosis) 12/2020 - 04/2010
3	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2021 - 11/2013
3	Adenocarcinoma 11/2020 - 04/2008
3	Hypotension (Low Blood Pressure) 10/2020 - 09/2011
3	Ovarian Neoplasms (Ovarian Cancer) 01/2019 - 11/2017
3	Exanthema (Rash) 01/2018 - 01/2006
3	Pain (Aches) 07/2017 - 11/2005
2	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 11/2017
2	Myalgia 10/2020 - 11/2016
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2020 - 07/2014
2	Nausea 10/2020 - 11/2016
2	Astigmatism 05/2017 - 01/2016
2	Myopia 05/2017 - 01/2016
2	Cognitive Dysfunction 01/2013 - 05/2011
2	Alzheimer Disease (Alzheimer's Disease) 05/2011 - 01/2003
1	Mood Disorders (Mood Disorder) 01/2022
1	Postpartum Depression (Post-Natal Depression) 01/2022
1	Melanoma (Melanoma, Malignant) 12/2020
1	Hyponatremia 10/2020
1	Alopecia (Baldness) 10/2020
1	Diarrhea 10/2020
1	Dehydration (Water Stress) 10/2020
1	Constipation 10/2020
1	Autoimmune Diseases of the Nervous System 10/2020
1	Uterine Neoplasms (Uterine Cancer) 01/2019
1	Otitis Media with Effusion 01/2019
1	Asthenia 01/2018
1	Dermatitis 01/2018
1	Depressive Disorder (Melancholia) 01/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Substance-Related Disorders (Drug Abuse) 01/2018

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2006
6	Naltrexone (ReVia)FDA LinkGeneric 01/2018 - 03/2016
6	ErbB Receptors (EGF Receptor)IBA 01/2018 - 01/2005
4	atezolizumabIBA 01/2021 - 01/2019
4	B7-H1 AntigenIBA 01/2021 - 01/2018
4	Monoclonal AntibodiesIBA 11/2020 - 01/2006
4	PlatinumIBA 01/2019 - 07/2005
4	Irinotecan (Camptosar)FDA LinkGeneric 10/2008 - 01/2006
3	Immunoglobulin G (IgG)IBA 12/2020 - 01/2006
3	Gemcitabine FDA Link 11/2020 - 04/2008
3	Opioid Analgesics (Opioids)IBA 01/2018 - 03/2016
3	Cetuximab (Erbitux)FDA Link 08/2007 - 05/2005
2	Immunoglobulins (Immunoglobulin)IBA 01/2023 - 12/2020
2	Immunoconjugates (Immunoconjugate)IBA 12/2020 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 12/2020 - 11/2013
2	GlucocorticoidsIBA 12/2020 - 01/2009
2	andecaliximabIBA 11/2020 - 01/2018
2	avelumabIBA 01/2019 - 01/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 05/2005
2	Carboplatin (JM8)FDA LinkGeneric 12/2014 - 07/2014
2	Fluorouracil (Carac)FDA LinkGeneric 10/2008 - 01/2006
2	Cyclin D1IBA 07/2006 - 05/2005
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2006 - 07/2005
2	Interleukin-8 (Interleukin 8)IBA 07/2005 - 05/2005
1	Essential Amino AcidsIBA 01/2022
1	Tryptophan (L-Tryptophan)FDA Link 01/2022
1	Tuberculin (PPD)IBA 01/2022
1	Tyrosine (L-Tyrosine)FDA Link 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	avapritinibIBA 01/2021
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2021
1	dabrafenibIBA 12/2020
1	trametinibIBA 12/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2020
1	Mitogen-Activated Protein KinasesIBA 12/2020
1	durvalumabIBA 12/2020
1	Mucin-1 (CA 15-3 Antigen)IBA 12/2020
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 12/2020
1	130-nm albumin-bound paclitaxelIBA 11/2020
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 11/2020
1	epacadostatIBA 10/2020
1	Oncogene Proteins (Oncogene Protein)IBA 10/2020
1	ripretinibIBA 10/2020
1	Aligeron (AS 2)IBA 01/2020
1	navicixizumabIBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	A 7 (A-7)IBA 01/2019
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2019
1	navoximodIBA 01/2019
1	insulin receptor-related receptor (IRR)IBA 01/2018
1	Therapeutic UsesIBA 01/2018
1	Lipase (Acid Lipase)FDA Link 01/2018

Therapy/Procedure

12	Therapeutics 01/2021 - 01/2002
9	Drug Therapy (Chemotherapy) 11/2020 - 07/2005
3	Laser In Situ Keratomileusis (LASIK) 05/2017 - 01/2015
3	Injections 03/2016 - 11/2005
2	Castration 01/2021 - 11/2017
2	Secondary Prevention 03/2015 - 05/2011
2	Conduction Anesthesia (Regional Anesthesia) 11/2011 - 09/2011
1	Immunotherapy 01/2020
1	Thermometers 01/2018
1	Intravenous Infusions 01/2018